Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Request a Policy / Feedback
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.32
    OpenPayerPolicy UpdatesClinical/Medical PolicyModa Health Hair Removal Coverage | OpenPayer
    Ask Trek AI about this page
    CurrentModa HealthPolicy N/A

    Hair removal procedures and treatment of other skin conditions (Hirsutism, Pilonidal Sinus Disease, Folliculitis treatment) (excluding gender-affirming care)

    Customize your policy alerts

    Sign up for all Moda Health policy alerts

    Know when Moda Health releases new policies or updates existing guidance.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    This policy governs Moda Health medical-necessity coverage and prior-authorization requirements for hair removal procedures used to treat hirsutism, pilonidal sinus disease or recurrent pilonidal cysts, and selected folliculitis. Gender-affirming care is excluded.

    Policy Summary
    PayerModa Health
    PolicyHair removal procedures and treatment of other skin conditions
    Policy CodePolicy N/A
    Change TypeMaterial revision
    Effective DateMay 1, 2026
    Last ReviewApr 22, 2026
    Next Review DateN/A
    Key ActionSubmit prior-authorization documentation, including diagnosis history, unsuccessful cosmetic management, relevant clinical information, and photographic evidence.
    SourceLink
    POLICY UPDATE CHANGES

    The policy revised the hair-removal modality language to link modality selection to hair color and treatment efficacy.

    The policy added a definition of idiopathic hirsutism.

    The policy explicitly excludes gender-affirming care.

    6 treatmentsMaximum covered hirsutism treatment course
    Every 4 weeksCovered treatment interval for the hirsutism course

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    FG ≥8Minimum hirsutism score for medically necessary hair removal
    1 yearRequired duration of unsuccessful cosmetic management for hirsutism
    3Required prior folliculitis treatment categories when applicable
    3Covered procedure codes listed

    Medical Necessity Coverage Criteria

    Hirsutism hair removal

    Covered as medically necessary when ALL of the following requirements are met:

    Core requirements

    • Patient and treatment criteria

      • Patient-important hirsutism: The patient is a woman with patient-important hirsutism, defined as unwanted sexual hair growth of any degree that causes sufficient distress to seek additional treatment.
      • Ferriman-Gallwey score: The patient has a documented Ferriman-Gallwey hirsutism score of 8 or greater.>= 8
      • Unsuccessful cosmetic management with daily shaving, waxing, or bleaching is documented over a period of at least one year.>= 1 year
      • Photographic evidence is supplied.
      • Modality selection: The hair-removal modality is selected based on hair color and treatment efficacy.

        Laser or photoepilation may be used for darker terminal hair; electrolysis is effective for all hair colors, including light or non-pigmented hair.

    • ONE qualifying underlying diagnosis

      • Congenital or endocrine condition

        • The patient has an underlying congenital abnormality leading to abnormally placed hair, such as non-classical congenital adrenal hyperplasia (NCCAH).
        • The patient has an endocrine condition leading to abnormally placed hair.
      • The patient has polycystic ovary syndrome (PCOS).
      • The patient has idiopathic hyperandrogenism.
      • The patient has idiopathic hirsutism, meaning hirsutism without hyperandrogenemia or other signs or symptoms indicative of a hyperandrogenic endocrine disorder.
    • Treatment-course limit: Only one course of treatment is covered.6 treatments every 4 weeks

    Pilonidal disease hair removal

    May be considered medically necessary when ALL of the following requirements are met:

    Qualifying disease and prior procedure

    • ONE qualifying condition

      • The patient has pilonidal sinus disease.
      • The patient has recurrent pilonidal cysts.
    • Qualifying prior treatment: The condition has been treated with a procedure performed to debride an accumulation of fluid or pus causing the formation of a cyst or abscess.

      Qualifying procedures include excision, incision and drainage, and phenol application.

    Folliculitis treatment

    Covered as medically necessary when ALL of the following requirements are met:

    Folliculitis laser hair removal

    • Qualifying folliculitis presentation

      • The patient has a diagnosis of folliculitis.
      • ONE qualifying presentation

        • The folliculitis has spread.
        • The folliculitis keeps coming back.
        • The affected area becomes red, swollen, warm, or more painful.

    Gender-affirming care is excluded from this policy. The policy applies to hair-removal procedures and treatment of hirsutism, pilonidal sinus disease, and folliculitis when the applicable medical-necessity criteria are met.

    Covered Services and Coding Parameters

    CPT or HCPC Codes CoveredCPTCovered
    17380Electrolysis hair removal
    17110Destruction (eg, laser surgery, electrosurgery, cryosurgery, chemosurgery, surgical curettement), of benign lesions other than skin tags or cutaneous vascular proliferative lesions; up to 14 lesions
    17111Lesions destruction (eg, laser surgery, electrosurgery, cryosurgery, chemosurgery, surgical curettement), of benign lesions other than skin tags or cutaneous vascular proliferative lesions; 15 or more lesions
    Applicable Diagnosis CodesICD-10
    L68.0Hirsutism
    Ferriman-Gallwey hirsutism score
    ScaleEach of nine body areas is scored from 0 to 4.
    Coverage thresholdA Ferriman-Gallwey score of 8 or greater supports covered hirsutism hair removal when other requirements are met.
    Normal rangeA total score less than 8 is considered normal.
    Unsuccessful cosmetic management
    Required durationAt least one year before hair-removal treatment is covered.
    Accepted methodsDaily shaving, waxing, or bleaching.

    Authorization and Documentation Requirements

    Prior Authorization

    Prior Authorization Documentation Required

    Submit a prior authorization request with the clinical records needed to evaluate medical necessity for the requested hair-removal procedure or folliculitis treatment.

    • Include diagnosis history, prior management, unsuccessful cosmetic management, relevant clinical information, and photographic evidence when applicable.
    Step Therapy

    Document Required Folliculitis Treatment Trial

    For laser hair removal treatment of folliculitis, document an inadequate response to or intolerance of all applicable prior treatments.

    • Medicated shampoo, when folliculitis affects the scalp or beard.
    • Topical antibiotic or antifungal, based on the etiology.
    • Oral antibiotic or antifungal, based on the etiology.

    Clinical Background

    Hirsutism is the growth of coarse, dark hair in androgen-sensitive areas where females typically have fine or absent hair. It is commonly associated with polycystic ovary syndrome or may be idiopathic. Severity is commonly assessed using the Ferriman-Gallwey scale, which scores nine body areas.

    Key Definitions and Scoring

    Patient-important hirsutism
    Hair growthUnwanted sexual hair growth of any degree.
    Patient impactThe hair growth causes sufficient distress.
    Treatment-seeking thresholdThe distress leads a female to seek additional treatment.
    Idiopathic hirsutism
    DefinitionHirsutism without hyperandrogenemia.
    Other findingsThere are no other signs or symptoms indicative of a hyperandrogenic endocrine disorder.
    Clinical classification
    Policy Summary
    PayerModa Health
    PolicyHair removal procedures and treatment of other skin conditions
    Policy CodePolicy N/A
    Change TypeMaterial revision
    Effective DateMay 1, 2026
    Last ReviewApr 22, 2026
    Next Review DateN/A
    Key ActionSubmit prior-authorization documentation, including diagnosis history, unsuccessful cosmetic management, relevant clinical information, and photographic evidence.
    SourceLink
    On This Page
    Medical Necessity Coverage CriteriaCovered Services and Coding ParametersAuthorization and Documentation RequirementsClinical BackgroundKey Definitions and Scoring
    Inadequate response or intolerance to ALL applicable therapies: The patient has had an inadequate response to or intolerance of all applicable treatments.

    Applicable treatments are: medicated shampoo for folliculitis of the scalp or beard; a topical antibiotic or antifungal, depending on the etiology of the folliculitis; and an oral antibiotic or antifungal, depending on the etiology of the folliculitis.

    Documentation
    Unsuccessful cosmetic management must be documented.
    Covered hirsutism treatment course
    Number of treatmentsSix treatments.
    Treatment intervalTreatments are provided every 4 weeks.
    Coverage limitOnly one course of treatment is covered.
    Step Therapy

    Required Cosmetic Management Trial

    For hirsutism hair-removal requests, document unsuccessful cosmetic management consisting of daily shaving, waxing, or bleaching for at least one year.

    • The cosmetic-management history must cover a period of at least one year.
    • Document which management methods were attempted and the patient’s response.
    Documentation Required

    Clinical History and Prior Management

    Submit the patient’s diagnosis history, prior management, and other relevant clinical information with the prior authorization request.

    • Include documentation supporting the requested indication and prior treatment history.
    • For hirsutism, include the relevant clinical history and qualifying diagnosis.
    Documentation Required

    Medical-Necessity Support for Hirsutism

    Support medical necessity for hirsutism hair removal by documenting patient-important hirsutism, a Ferriman-Gallwey score of 8 or greater, unsuccessful cosmetic management for at least one year, photographic evidence, and a qualifying diagnosis.

    • Patient-important hirsutism means unwanted sexual hair growth causing sufficient distress to seek additional treatment.
    • Qualifying diagnoses include NCCAH or another congenital abnormality causing abnormally placed hair, an endocrine condition causing abnormally placed hair, PCOS, idiopathic hyperandrogenism, or idiopathic hirsutism.
    • Document that the selected modality is appropriate for hair color and treatment efficacy: laser or photoepilation may be used for darker terminal hair, while electrolysis is effective for all hair colors, including light or non-pigmented hair.
    Denial Risk

    Hirsutism Criteria Not Met

    A hirsutism hair-removal request may be denied when the required clinical significance, score, diagnosis, cosmetic-management history, or supporting evidence is not documented.

    • No patient-important distress or insufficient clinical significance.
    • Ferriman-Gallwey score below 8 or score not submitted.
    • No qualifying diagnosis or qualifying diagnosis not documented.
    • Unsuccessful daily shaving, waxing, or bleaching is not documented for at least one year.
    • Required photographic evidence is missing.
    Billing Rule

    Treatment Limit: One Six-Treatment Course

    Only one course of hirsutism hair-removal treatment is covered, consisting of six treatments administered at four-week intervals.

    • Requests exceeding one six-treatment course are not covered under this policy.
    Documentation Required

    Pilonidal Treatment Prerequisite

    For pilonidal sinus disease or recurrent pilonidal cysts, document the qualifying disease and prior treatment before requesting hair removal, including electrolysis or laser.

    • The condition must be pilonidal sinus disease or recurrent pilonidal cysts.
    • The cyst or abscess must have been treated with a procedure to debride the accumulation of fluid or pus.
    • Qualifying procedures include excision, incision and drainage, or phenol application.
    Denial Risk

    Pilonidal Criteria Not Met

    A pilonidal hair-removal request may be denied when qualifying pilonidal disease or the required prior cyst or abscess treatment is absent or not documented.

    • No pilonidal sinus disease or recurrent pilonidal cyst diagnosis.
    • No documented prior excision, incision and drainage, or phenol application for the qualifying cyst or abscess.
    Denial Risk

    Folliculitis Criteria or Treatment Failure Absent

    Laser hair removal for folliculitis requires both a qualifying folliculitis presentation and inadequate response to or intolerance of all applicable prior therapies.

    • Qualifying presentation: folliculitis has spread, keeps recurring, or causes redness, swelling, warmth, or increased pain.
    • Required prior-treatment failure or intolerance must include applicable medicated shampoo, topical antibiotic or antifungal, and oral antibiotic or antifungal therapy.
    Denial Risk

    Excluded Indication: Gender-Affirming Care

    Gender-affirming care is excluded from this policy and is not eligible for coverage under these criteria.

    • Do not submit requests for gender-affirming care under this policy.
    This presentation is termed idiopathic hirsutism.
    Ferriman-Gallwey score
    Body areasThe scale assesses nine areas of the body.
    Scoring rangeEach area receives a score from 0 to 4; 0 indicates absence of terminal hair.
    InterpretationA total score below 8 is normal, 8 to 15 indicates mild hirsutism, and greater than 15 indicates moderate to severe hirsutism.